Dosing schedule (per Health Canada ): Starter dose: 0.25 mg once weekly for the first 4 weeks Increase: 0.5 mg after Week 4, if tolerated Further titration: Up to 1 mg or more, depending on your treatment plan The gradual increases, occurring every 4 weeks, are designed to minimize side effects and promote a safer, more sustainable treatment response
However, high doses ( 0.5 mg/kg/d) may activate the SREBP-1c pathway, increase liver fat synthesis, and lead to hypertriglyceridemia and fatty liver
An overall benefit of the family of GLP-1RAs was in weight management
For example, ES-exposed offspring exhibited increased ROS [195], decreased ATP production [195, 196], higher oxidative stress [197] and decreased antioxidant levels [196] and altered mitochondrial gene expression [198] in the hippocampus when compared to controls
But here's the catch: GLP-1 is a complex peptide, a large molecule